Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020
30 janv. 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or the “Company”) a veterinary diagnostic and pharmaceutical...
Zomedica to Focus on TRUFORMA™ Commercialization
23 janv. 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), announced today that it intends to focus on the final development and...
Zomedica Successfully Completes Development and Manufacturing Milestones for its Cancer Liquid Biopsy Platform
20 janv. 2020 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Jan. 20, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced it has...
Zomedica Announces Management Changes
03 déc. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Dec. 03, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (“Zomedica”) (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, announced that...
Zomedica Expands ZM-006 Pilot Efficacy Study
13 nov. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, announced today that it has...
Zomedica Announces Third Quarter 2019 Financial Results
12 nov. 2019 16h53 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company,...
Zomedica Announces 2019 Annual Meeting Results
05 nov. 2019 16h15 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, is pleased to...
Zomedica Commences Final TRUFORMA™ Diagnostic Verification Study
31 oct. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, announced today that it has...
Zomedica names Dr. Stephanie Morley President
17 sept. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that Dr....
Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference
03 sept. 2019 06h55 HE
|
Zomedica Pharmaceuticals Corp.
ANN ARBOR, Mich., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it...